Abera Bioscience AB (NGM:ABERA)
Sweden
· Delayed Price · Currency is SEK 6.60
+0.15 (2.33%)
At close: Dec 3, 2025
Abera Bioscience AB Revenue
Abera Bioscience AB had revenue of 4.92M SEK in the quarter ending September 30, 2025, with 46.92% growth. This brings the company's revenue in the last twelve months to 17.30M, up 37.23% year-over-year. In the year 2024, Abera Bioscience AB had annual revenue of 14.63M with 479.60% growth.
Revenue (ttm)
17.30M
Revenue Growth
+37.23%
P/S Ratio
7.20
Revenue / Employee
3.46M
Employees
5
Market Cap
124.52M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 133.31B |
| Atlas Copco AB | 171.55B |
| AB Volvo | 493.79B |
| ASSA ABLOY AB | 153.68B |
| EQT AB | 30.08B |
| Skandinaviska Enskilda Banken AB | 76.49B |
| Sandvik AB | 120.37B |
| Swedbank AB | 70.81B |